Purchase Order 75N92B25P00248
Award Date
8/4/25
Potential Completion Date
8/3/26
Potential Value
$20K
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
339113 - Surgical Appliance and Supplies Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit organization and manufacturer of genetic sequencing and genomic analysis technologies. The $23,443.44 contract has an ultimate completion date of April 30, 2026 and does not utilize any set-aside designations. The contract provides for the procurement of Illumina's advanced sequencing instruments, reagents,...
This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The contract has a ceiling value of $248,907.23 and runs through September 2025. There is no set-aside designation. Illumina will provide a range of its sequencing systems, consumables, and bioinformatics products to support genomic research and...
This is a $217,193.76 delivery order awarded to Illumina, Inc., a for-profit manufacturer of genetic sequencing and genomic analysis technologies, by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health. The award has a firm fixed price contract type and an ultimate completion date of March 2, 2026. Illumina has been awarded multiple federal contracts and Indefinite Delivery Vehicles (IDVs) from agencies like the U.S. Department of...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $144,182.10 contract is to provide Illumina sequencing systems, reagents, and related products and services to support genomic research and analysis at the NIH. Illumina has a history of...
This firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $12,058.24 contract is for the procurement of Illumina sequencing kits and does not have a set-aside designation. Illumina has been awarded multiple prime federal contracts and grants, primarily focused on providing advanced genomic sequencing...
This is a federal contract award to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis solutions, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH). The $199,073.27 firm-fixed price Delivery Order contract is for the provision of sequencing systems, reagents, and related services to support genomic research and diagnostics. This award was not subject to small business set-aside...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
This is a firm fixed-price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for $101,126.67. The contract is for the provision of Illumina's proprietary genomic sequencing systems, reagents, and related services to support NIAMS's research and diagnostic needs. Illumina has a history of providing similar products and services to other federal...
This firm fixed-price purchase order contract was awarded by the National Human Genome Research Institute, a component of the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $16,691.74 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously been awarded prime federal...
This is a $154,713.12 firm fixed price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract is not associated with a set-aside program. Illumina will provide sequencing systems, reagents, and maintenance services to support genomic research and analysis across a range of federal agencies, including the NIH, CDC, USDA, and VA. Illumina has previously been...